Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kissei Pharmaceutical Co ( (JP:4547) ) has shared an update.
Kissei Pharmaceutical will mark the 80th anniversary of its founding on August 9, 2026, and is using this milestone to reinforce its medium-term management plan “Beyond 80,” which targets sustainable growth as a research-driven drug maker while signaling continued commitment to shareholder returns. The board has approved special commemorative dividends in two stages: an additional ¥40 per share on top of the ordinary year-end dividend for the fiscal year ending March 31, 2026, lifting the total full-year dividend forecast to ¥160 per share from a previous ¥120 and significantly above the prior year’s ¥100, and a further ¥40 per share as part of the interim dividend for the fiscal year ending March 31, 2027, underscoring a more shareholder-friendly capital policy that may enhance the stock’s appeal and highlight confidence in the company’s financial footing.
The most recent analyst rating on (JP:4547) stock is a Hold with a Yen4900.00 price target. To see the full list of analyst forecasts on Kissei Pharmaceutical Co stock, see the JP:4547 Stock Forecast page.
More about Kissei Pharmaceutical Co
Kissei Pharmaceutical Co., Ltd. is a Japan-based R&D-oriented pharmaceutical company listed on the Tokyo Stock Exchange Prime Market, focusing on the development and commercialization of prescription drugs and related healthcare products for domestic and international markets.
Average Trading Volume: 66,884
Technical Sentiment Signal: Buy
Current Market Cap: Yen185B
Learn more about 4547 stock on TipRanks’ Stock Analysis page.